Stefan Zeuzem, MD, provides a rapid update on the key hepatology studies anticipated to affect clinical practice.
In this downloadable slideset, expert faculty members Paul Y Kwo, MD, Nancy Reau, MD, FAASLD, AGAF, and Stefan Zeuzem, MD, highlight key studies from this important annual conference.
Genotype 3 HCV infection is concerning, not just because of its natural history but also because of its potential role in reinfection. New data from EASL offer promise for the treatment of this challenging patient population.
Here’s my take on new data from EASL 2017.
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.